BCL10 (MALT-Lymphoma Marker)
Product Sizes
0.1 mg
£ POA
MBS4380730-0.1MG
About this Product
- SKU:
- MBS4380730
- Additional Names:
- B-cell lymphoma/leukemia 10 isoform 1; B-cell lymphoma/leukemia 10; B-cell lymphoma/leukemia 10; BCL10, immune signaling adaptor; B-cell CLL/lymphoma 10; Bcl-10; CARD-containing molecule enhancing NF-kappa-B; CARD-like apoptotic protein; hCLAP; CED-3/ICH-1 prodomain homologous E10-like regulator; CIPER; Cellular homolog of vCARMEN; cCARMEN; Cellular-E10; c-E10; Mammalian CARD-containing adapter molecule E10; mE10; B-cell CLL/lymphoma 10; B-cell leukemia/lymphoma 10; CARD-containing molecule enhancing NF-kappa-B; CARD-like apoptotic protein; caspase-recruiting domain-containing protein; CED-3/ICH-1 prodomain homologous E10-like regulator; Cellular homolog of vCARMEN; Cellular-E10 (cE10); CIPER; hCLAP; mE10; R-RCD1
- Application:
- IHC-Paraffin
- translate.label.attr.clone:
- [BL10/2988R]
- Clonality:
- Monoclonal
- Host:
- Rabbit
- Isotype:
- IgG
- Physical State:
- 200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
- Purity:
- Purified Ab with BSA and Azide at 200ug/ml OR Purified Ab WITHOUT BSA and Azide at 1.0mg/ml
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Specificity:
- BCL10, with an N-terminal caspase recruitment domain (CARD), is found in a number of apoptotic regulatory molecules. It was identified through its direct involvement in t(1; 14) of mucosa-associated lymphoid tissue (MALT) lymphoma. Expression of BCL10 was shown to induce NFkappaB activation in a NIK-dependent pathway. This MAb labels subpopulations of normal B and T cells and is a useful tool for
- Storage Conditions:
- Please refer to datasheet
- Supplier:
- MyBioSource
- Type:
- Antibody: Monoclonal Antibody
- Manufacturer's Data Sheet:MBS4380730
